Martim Prado Mattos

Director/Board Member at

Bionovis SA

45 year

72 connections

Consumer Services

Health Technology

Finance

Profile

Martim Prado Mattos is currently a Director at Bionovis SA. Previously, he worked as the Chief Financial Officer & Controller at Hypera SA from 2013 to 2014 and as a Financial Analyst at Monte Cristalina LTDA. He received his undergraduate degree from Getulio Vargas Foundation in 2005 and another undergraduate degree from Faculdade de Economia, Administração e Contabilidade da in 2011.

Martim Prado Mattos active positions

Companies	Position	Start
Bionovis SA Bionovis SA Pharmaceuticals: OtherHealth Technology Produces and markets biological and biosimilar medicines	Director/Board Member	-

All active positions of Martim Prado Mattos

Former positions of Martim Prado Mattos

Companies	Position	End
Monte Cristalina LTDA Monte Cristalina LTDA Financial ConglomeratesFinance Invests in companies	Corporate Officer/Principal	-
HYPERA S.A.	Director of Finance/CFO	-

See the detail of Martim Prado Mattos's experience

Training of Martim Prado Mattos

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Martim Prado Mattos's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	5
Getulio Vargas Foundation Getulio Vargas Foundation Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Hypera SA Hypera SA Pharmaceuticals: MajorHealth Technology Manufactures and distributes medical and cosmetics products	Health Technology
Monte Cristalina LTDA Monte Cristalina LTDA Financial ConglomeratesFinance Invests in companies	Finance
Faculdade de Economia, Administração e Contabilidade da Faculdade de Economia, Administração e Contabilidade da Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Bionovis SA Bionovis SA Pharmaceuticals: OtherHealth Technology Produces and markets biological and biosimilar medicines	Health Technology